Oxonica has raised approximately £7.1m (net of expenses) through a placing of 8,658,796 new ordinary shares at 95.8 pence per share. In addition, Oxonica shareholders have converted loans of approximately £2m into ordinary shares at 95.8 pence per share, which together with the placing strengthens the balance sheet by £9.1m.
Buyer adds cosmetic surgery chain to portfolio of healthcare assets; is targeting IPO on Nordic Growth markets
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Fund-of-funds has made two investments to date and plans to attract further European institutional LPs
Acquisition of the Swedish customer and employee feedback platform follows a Houlihan Lokey-led sale process